GEODE CAPITAL MANAGEMENT, LLC - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 155 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$9,792,453
+43.9%
2,320,210
+5.7%
0.00%0.0%
Q2 2023$6,804,472
+161.0%
2,194,991
+17.0%
0.00%
Q1 2023$2,607,254
+71508.2%
1,875,723
+2.5%
0.00%
-100.0%
Q4 2022$3,641
-99.9%
1,830,098
+2.6%
0.00%0.0%
Q3 2022$3,601,000
-34.6%
1,783,158
+3.0%
0.00%0.0%
Q2 2022$5,506,000
-22.9%
1,731,568
+1.1%
0.00%0.0%
Q1 2022$7,141,000
-15.3%
1,712,671
-2.7%
0.00%0.0%
Q4 2021$8,435,000
-2.5%
1,761,057
+8.7%
0.00%0.0%
Q3 2021$8,650,000
-10.3%
1,619,999
-14.0%
0.00%0.0%
Q2 2021$9,639,000
-21.4%
1,882,710
+3.3%
0.00%
-50.0%
Q1 2021$12,260,000
+63.7%
1,821,717
+11.2%
0.00%
+100.0%
Q4 2020$7,489,000
+20.7%
1,638,785
+2.5%
0.00%0.0%
Q3 2020$6,206,000
-19.8%
1,599,517
-1.6%
0.00%
-50.0%
Q2 2020$7,737,000
+30.3%
1,625,596
-4.7%
0.00%0.0%
Q1 2020$5,938,000
-59.3%
1,706,562
-43.6%
0.00%0.0%
Q4 2019$14,588,000
+313.3%
3,026,644
+148.6%
0.00%
+100.0%
Q3 2019$3,530,000
-52.9%
1,217,363
+16.4%
0.00%
-50.0%
Q2 2019$7,495,000
-44.5%
1,045,427
+9.6%
0.00%
-50.0%
Q1 2019$13,512,000
-43.9%
953,580
-46.4%
0.00%0.0%
Q4 2018$24,082,000
+38.9%
1,779,960
+127.8%
0.00%
-20.0%
Q3 2018$17,342,000
+42.6%
781,525
+5.4%
0.01%
+25.0%
Q2 2018$12,162,000741,1840.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$83,503,0007.34%
Eversept Partners, LP 2,656,208$10,306,0872.29%
TPG Group Holdings (SBS) Advisors, Inc. 16,213,367$62,908,0001.13%
Prosight Management, LP 512,659$1,989,0000.95%
THB ASSET MANAGEMENT 833,104$3,232,0000.90%
GLOBEFLEX CAPITAL L P 251,696$977,0000.26%
XTX MARKETS LLC 10,243$40,0000.19%
HUSSMAN STRATEGIC ADVISORS, INC. 102,000$396,0000.10%
PA Capital LLC 33,874$132,0000.09%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 60,900$236,0000.07%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders